Skip to main content
. 2017 Nov 1;2017(11):CD008077. doi: 10.1002/14651858.CD008077.pub5
Methods Randomised parallel controlled trial
Participants Baseline: 60 participants were divided into 3 groups. We reported the results of 20 participants in the 10‐second heparin injection group and 20 participants in the 30‐second heparin injection group ‐ 13 male and 27 female; mean age in the intervention group was 62.7 (SD 8.83) years and in the control group 57.9 (SD 12.5) years.
Setting: patients who were hospitalised in the orthopedic wards of a university hospital in Turkey
Country: Turkey
Injection site: LMWH was injected SC into the tissue of the lower abdominal wall (umbilical region)
Injection protocol: insertion angle 90°, grasping of tissue at injection site, injection without drug aspiration
Inclusion criteria: 18 years of age or older, received SC injections of LMWH once a day, had normal platelet values, were conscious, did not have any complications in the perioperative days, did not have acute painful disease
Exclusion criteria: were pregnant, had abnormalities of coagulation or haematologic and allergic diseases, received any other injections at the abdominal site during the days of the research, had any incision or scar tissue at the abdominal site
Interventions Slow injection (30 seconds) vs fast injection of heparin (10 seconds)
Outcomes Site pain intensity was assessed by VAS (0 to 100 mm) immediately, and at 48, 60, and 72 hr after injection.
Injection site bruising was evaluated at 48, 60, and 72 hr after each injection with a transparent mm ruler to measure the surface area of the bruise and record it as mm2.
Notes Study authors were contacted about any use of anticoagulant drugs; they reported that participants were excluded if participants took any anticoagulant drugs before the start of the study.
Funding sources: not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "A computerized randomisation program was used to allocate the patients."
Allocation concealment (selection bias) Unclear risk Method not stated
Blinding of participants and personnel (performance bias) All outcomes High risk Quote: "non‐blinded study design was used."
Blinding of outcome assessment (detection bias) All outcomes High risk Quote: "non‐blinded study design was used."
Incomplete outcome data (attrition bias) All outcomes High risk 6.25% dropout after randomisation in the intervention group, as 4 participants were hospitalised in intensive care unit after randomisation. Use of intention‐to‐treat analysis was not reported.
Selective reporting (reporting bias) Low risk All stated outcomes were reported.
Other bias Unclear risk Other aspects of heparin injection (e.g. heparin temperature, syringe size, injection volume, air bubble in the syringe) were not clearly described. This may have affected study outcomes.